| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/09/2011 | CA2671595A1 Controlled nitric oxide delivery from aqueous s-nitrosothiol conjugated polymers and their complexes |
| 01/06/2011 | WO2011003062A2 Probiotic compositions and processes thereof |
| 01/06/2011 | WO2011001212A1 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation |
| 01/06/2011 | WO2011001181A1 Antimicrobial material |
| 01/06/2011 | WO2011000930A1 L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin |
| 01/06/2011 | WO2011000863A1 Sulfonamide derivatives for use in the treatment of skin conditions |
| 01/06/2011 | WO2011000767A1 New medical use |
| 01/06/2011 | WO2011000765A1 New medical use |
| 01/06/2011 | WO2011000218A1 Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders |
| 01/06/2011 | WO2010119102A3 Pharmaceutical composition containing proton pump inhibitor for treating dermatological autoimmune diseases |
| 01/06/2011 | WO2010107251A3 Pharmaceutical composition used in prophylaxis or treatment of hyperproliferative skin conditions and malignant melanomas comprising pachastrissamine as active ingredient |
| 01/06/2011 | WO2010099319A3 Composition and methods for clotting blood |
| 01/06/2011 | WO2009109402A8 Composition and uses for influencing hair growth |
| 01/06/2011 | US20110004164 Non-sedating antihistamine injection formulations and methods of use thereof |
| 01/06/2011 | US20110003987 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |
| 01/06/2011 | US20110003898 Medical glues for surgery comprising bioactive compounds |
| 01/06/2011 | US20110003894 Dermatological compositions comprising retinoids, dispersed benzoyl peroxide and carrageenans |
| 01/06/2011 | US20110003892 All-trans retinoid esters as active pharmaceutical ingredients, oral and topical dosage form compositions thereof, and methods of treating skin conditions thereof |
| 01/06/2011 | US20110003876 Tetrahydroindoles Having Sphingosine-1-Phosphate Receptor Activity |
| 01/06/2011 | US20110003874 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 01/06/2011 | US20110003864 Crystalline 1-(3-fluorophenyl)-5-methyl-2-(1h)pyridone, the preparation methods, compositions and applications thereof |
| 01/06/2011 | US20110003853 Metalloproteinase Inhibitors |
| 01/06/2011 | US20110003843 Novel compounds derived from indole and pharmaceutical compositions containing them |
| 01/06/2011 | US20110003824 Caspase Inhibitors and Uses Thereof |
| 01/06/2011 | US20110003798 Compounds and compositions as kinase inhibitors |
| 01/06/2011 | US20110003797 HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 01/06/2011 | US20110003792 Anti-inflammatory agents |
| 01/06/2011 | US20110003790 Pyrido [4, 3-d] pyrimidinone derivatives as kinase inhibitors |
| 01/06/2011 | US20110003773 Using fullerenes to enhance and stimulate hair growth |
| 01/06/2011 | US20110003769 Anti-aging composition for external use comprising low and high molecular weight hyaluronic acids and the polysaccharides extracted from root bark of ulmus davidiana |
| 01/06/2011 | US20110003766 Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as a2ar agonists |
| 01/06/2011 | US20110003763 Avermectin/benzoyl peroxide compositions for treating afflictions of the skin, e.g., rosacea |
| 01/06/2011 | US20110003760 Abnormal protein removing method |
| 01/06/2011 | US20110003759 Non-basic melanin concentrating hormone receptor-1 antagonists and methods |
| 01/06/2011 | US20110003756 C5a Receptor Antagonists |
| 01/06/2011 | US20110003750 Human 3 relaxin |
| 01/06/2011 | US20110003747 Use of nrf2 inducers to treat epidermolysis bullosa simplex and related diseases |
| 01/06/2011 | US20110003388 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 01/06/2011 | US20110003360 Delta-6 desaturase and uses thereof |
| 01/06/2011 | US20110003351 Delta-5 desaturase and uses thereof |
| 01/06/2011 | US20110003016 Hair care composition |
| 01/06/2011 | US20110003008 Mesenchymal stem cell particles |
| 01/06/2011 | US20110003001 Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications |
| 01/06/2011 | US20110002999 Biopolymer System for Tissue Sealing |
| 01/06/2011 | US20110002997 Photoinitiated tissue filler |
| 01/06/2011 | US20110002994 Method of regulating the th17 pathway and its associated metabolic impact |
| 01/06/2011 | US20110002984 Formulations comprising exine shells |
| 01/06/2011 | US20110002983 Compound |
| 01/06/2011 | US20110002969 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
| 01/06/2011 | US20110002968 Cosmetic or dermatological composition containing an orchid extract, and cosmetic care method using said composition |
| 01/06/2011 | US20110002965 Immunomodulating compounds and related compositions and methods |
| 01/06/2011 | US20110002952 FUSED HETEROARYL MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kappaB ACTIVITY AND USE THEREOF |
| 01/06/2011 | US20110002942 Engineered Anti-IL-23 Antibodies |
| 01/06/2011 | US20110002939 monoclonal antibody and a method thereof |
| 01/06/2011 | US20110002936 Anti-IL-6/IL-6R Antibodies and Methods of Use Thereof |
| 01/06/2011 | US20110002931 Bispecific antibodies that bind to complement proteins |
| 01/06/2011 | US20110002883 Therapeutic preparations containing wharton's jelly |
| 01/06/2011 | US20110002880 Material For Wound Healing and Skin Reconstruction |
| 01/06/2011 | US20110002876 Multimeric VLA-4 Antagonists Comprising Polymer Moieties |
| 01/06/2011 | US20110002868 Cationic synthetic polymers with improved solubility and performance in surfactant-based systems and use in personal care and household applications |
| 01/06/2011 | US20110002866 Methods to prevent a hair-related side effect of treatment with a chemotherapeutic agent |
| 01/06/2011 | US20110002865 Moisturizing cosmetic composition comprising a combination of homarine and erythritol |
| 01/06/2011 | US20110002861 Composition comprising pure aloe and its use as a cosmetic base |
| 01/06/2011 | US20110002857 Oleaginous pharmaceutical and cosmetic foam |
| 01/06/2011 | CA2769627A1 Antimicrobial/preservative compositions comprising botanicals |
| 01/06/2011 | CA2766967A1 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation |
| 01/06/2011 | CA2766834A1 Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders |
| 01/06/2011 | CA2766706A1 L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin |
| 01/06/2011 | CA2765920A1 Antimicrobial material |
| 01/05/2011 | EP2270049A2 Recombinant anti-interleukin-9-antibody |
| 01/05/2011 | EP2270042A2 KDR peptides and vaccines comprising the same |
| 01/05/2011 | EP2270041A2 KDR peptides and vaccines comprising the same |
| 01/05/2011 | EP2270005A1 Prodrug of an ice inhibitor |
| 01/05/2011 | EP2269988A2 Anthranilic acid amides and pharmaceutical use thereof |
| 01/05/2011 | EP2269656A2 Selected antibodies binding to anionic phospholipids and aminophospholipids and their use in treatment |
| 01/05/2011 | EP2269654A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 01/05/2011 | EP2269645A2 Topical aminolevulinic acid-photodynamic therapy for acne vulgaris |
| 01/05/2011 | EP2269621A1 Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents |
| 01/05/2011 | EP2268300A2 Methods for the inhibition of scarring |
| 01/05/2011 | EP2268299A1 Compositions and method for reducing scar formation in wound healing |
| 01/05/2011 | EP2268291A2 Treatment for the hair regrowth in the bald patches formed by alopecia of the celsi area |
| 01/05/2011 | EP2268279A1 Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl¨-3-oxoisoindoline-4-yl}carboxamide |
| 01/05/2011 | EP2268260A1 Means and methods for controlling commensales |
| 01/05/2011 | EP2268257A2 Compositions based on polymer/hydrogen peroxide complexes and uses thereof |
| 01/05/2011 | EP1937281B1 Modulation of trpv expression levels |
| 01/05/2011 | EP1771180B2 Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase |
| 01/05/2011 | EP1765356B2 Spray composition comprising a combination of calcitriol and clobetasol propionate, an alcoholic phase, at least one volatile silicone and one non volatile oily phase |
| 01/05/2011 | EP1623718B1 Skin collagen production promoter |
| 01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 01/05/2011 | EP1446381B1 Anthranilic acid amides and pharmaceutical use thereof |
| 01/05/2011 | EP1147214B1 A novel method for designing protein kinase inhibitors |
| 01/05/2011 | DE102010030443A1 Cosmetic composition, useful e.g. for the prophylaxis and treatment of dry sensitive skin or eczematous and psoriatic skin, comprises cobalamin and an extract of plant of the family Berberidaceae, preferably from the genus Mahonia |
| 01/05/2011 | CN201692331U Equipment for preparing nano level pearl powder |
| 01/05/2011 | CN101939327A New macrolides and their use |
| 01/05/2011 | CN101939030A Use of alginate oligomers in combating biofilms |
| 01/05/2011 | CN101939025A Therapeutic agent for pruritus |
| 01/05/2011 | CN101939012A Macrolides for treating diseases mediated through PDE inhibition |
| 01/05/2011 | CN101938989A Skin whitening agent and external preparation for the skin |
| 01/05/2011 | CN101938988A Skin whitening agent and external preparation for the skin |
| 01/05/2011 | CN101935349A Humanized monoclonal antibody against human vascular endothelial growth factor and preparation and application thereof |